Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 237

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial

Open access
Van Mieghem, Nicolas M., van Gils, Lennart, Ahmad, Habib, van Kesteren, Floortje, van der Werf, Hendrik W., Brueren, Guus, Storm, Michiel, Lenzen, Mattie, Daemen, Joost, van den Heuvel, Ad F.M., Tonino, Pim, Baan, Jan, Koudstaal, Peter J., Schipper, Marguerite E.I., van der Lugt, Aad, de Jaegere, Peter P.T. · 2016 · EuroIntervention

Abstract

AIMS: Our aim was to determine whether use of the filter-based Sentinel™ Cerebral Protection System (CPS) during transcatheter aortic valve implantation (TAVI) can affect the early incidence of new brain lesions, as assessed by diffusion-weighted magnetic resonance imaging (DW-MRI), and neurocognitive performance. METHODS AND RESULTS: From January 2013 to July 2015, 65 patients were randomised 1:1 to transfemoral TAVI with or without the Sentinel CPS. Patients underwent DW-MRI and extensive neurological examination, including neurocognitive testing one day before and five to seven days after TAVI. Follow-up DW-MRI and neurocognitive testing was completed in 57% and 80%, respectively. New brain lesions were found in 78% of patients with follow-up MRI. Patients with the Sentinel CPS had numerically fewer new lesions and a smaller total lesion volume (95 mm3 [IQR 10-257] vs. 197 mm3 [95-525]). Overall, 27% of Sentinel CPS patients and 13% of control patients had no new lesions. Ten or more new brain lesions were found only in the control cohort (in 20% vs. 0% in the Sentinel CPS cohort, p=0.03). Neurocognitive deterioration was present in 4% of patients with Sentinel CPS vs. 27% of patients without (p=0.017). The filters captured debris in all patients with Sentinel CPS protection. CONCLUSIONS: Filter-based embolic protection captures debris en route to the brain in all patients undergoing TAVI. This study suggests that its use can lead to fewer and overall smaller new brain lesions, as assessed by MRI, and preservation of neurocognitive performance early after TAVI. CLINICAL TRIAL REGISTRATION: Dutch trial register-ID: NTR4236. URL http://www.trialregister.nl/trialreg/admin/rctsearch.asp?Term=mistral.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4244/eijv12i4a84

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 237

Metadata

Authors
Van Mieghem, N. M., van Gils, L., Ahmad, H., van Kesteren, F., van der Werf, H. W., Brueren, G., Storm, M., Lenzen, M., Daemen, J., van den Heuvel, A. F. M., Tonino, P., Baan, J., Koudstaal, P. J., Schipper, M. E. I., van der Lugt, A., & de Jaegere, P. P. T.
Venue
EuroIntervention
Published
2016-07
Volume
12
Issue
4
Pages
499-507
ISSN
1774-024X (ISSN-L)
OpenAlex
W2493934914
Cited by
237
References
5
FWCI
16.19
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. https://app.cochat.ai/papers/10.4244/eijv12i4a84
The paper
Van Mieghem, N. M., van Gils, L., Ahmad, H., van Kesteren, F., van der Werf, H. W., Brueren, G., Storm, M., Lenzen, M., Daemen, J., van den Heuvel, A. F. M., Tonino, P., Baan, J., Koudstaal, P. J., Schipper, M. E. I., van der Lugt, A., & de Jaegere, P. P. T. (2016). Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention. https://doi.org/10.4244/eijv12i4a84

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.